References
- Aarflot T, Lerum E, Bruusgaard D. Uric acid and chronic musculoskeletal complaints. Scand J Rheumatol 1992; 21: 277–82
- Yunus M B, Masi A T, Calabro J J, Miller K A, Feigenbaum S L. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; II: 151–71
- Wolfe F, Smythe H A, Yunus M B, et al. The American College of Rheumatology 1990 criteria for classification of fibromyalgia. (Report of the Multicenter Criteria Committee). Arthritis Rheum 1990; 33: 160–72
- Wyngaarden J B, Kelley W N. Gout and hyperuricemia. Grune and Stratton Inc., New York 1976
- Kelley W N, Fox I H, Palella T D. Gout and related disorders of purine metabolism. Textbook of Rheumatology, W N Kelley, E D Harris, S Ruddy, C B Sledge. W. B. Saunders Company, Philadelphia 1989; 1395–448
- Campbell S M, Clark S, Tindall E A, Forehand M E, Bennett R M. Clinical characteristics of fibrositis. Arthritis Rheum 1983; 26: 817–24
- Moldofsky H, Lue F A, Natarjan M N, Reynolds W J. Seasonality of pain, mood energy and sleep in fibromyalgia vs. rheumatoid arthrilis. Scand J Rheumatol 1992; 21(Suppl 94)4
- Goldenberg D L, Felson D T, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29: 1371–7
- Goldenberg D L. Fibromyalgia: Treatment programs. Scand J Rheumatol 1992; 21(Suppl 94)5
- Postlethwaite A E, Ramsdell C M, Kelley W N. Uricosuric effect of an anticholinergic agent in hyperuricemic subjects. Arch Intern Med 1974; 134: 270